COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series

Mult Scler Relat Disord. 2020 Jul:42:102192. doi: 10.1016/j.msard.2020.102192. Epub 2020 May 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Multiple Sclerosis*
  • Pandemics
  • Pharmacovigilance
  • Pneumonia, Viral
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • ocrelizumab